Clinical and Diagnostic Laboratory Immunology, March 2001, p. 370-375, Vol. 8, No. 2
1071-412X/01/$04.00+0 DOI: 10.1128/CDLI.8.2.370-375.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Rhesus Monkey (Macaca mulatta) Mucosal
Antimicrobial Peptides Are Close Homologues of Human
Molecules
Robert
Bals,1,*
Christiane
Lang,2
Daniel J.
Weiner,3,4
Claus
Vogelmeier,1
Ulrich
Welsch,2 and
James M.
Wilson3
Medizinische Klinik und Poliklinik I,
Hospital of the University of Munich, Campus
Großhadern,1 and Anatomische
Anstalt,2 Ludwig-Maximilians-Universität,
Munich, Germany, and Institute for Human Gene Therapy,
Department of Medicine and Molecular and Cellular Engineering,
University of Pennsylvania and The Wistar
Institute,3 and Division of
Pulmonary Medicine, Children's Hospital of
Philadelphia,4 Philadelphia, Pennsylvania 19104
Received 31 July 2000/Returned for modification 19 October
2000/Accepted 5 December 2000
 |
ABSTRACT |
One component of host defense at mucosal surfaces appears to be
epithelium-derived antimicrobial peptides. Molecules of the defensin
and cathelicidin families have been studied in several species,
including human and mouse. We describe in this report the
identification and characterization of rhesus monkey homologues of
human mucosal antimicrobial peptides. Using reverse transcriptase PCR
methodology, we cloned the cDNAs of rhesus monkey
-defensin 1 and 2 (rhBD-1 and rhBD-2) and rhesus monkey LL-37/CAP-18 (rhLL-37/rhCAP-18). The predicted amino acid sequences showed a high degree of homology to
the human molecules. The expression of the monkey antimicrobial peptides was analyzed using immunohistochemistry with three polyclonal antibodies to the human molecules. As in humans, rhesus monkey antimicrobial peptides are expressed in epithelia of various organs. The present study demonstrates that
-defensins and cathelicidins of
rhesus monkeys are close homologues to the human molecules and indicate
that nonhuman primates represent valid model organisms to study innate
immune functions.
 |
INTRODUCTION |
Antimicrobial peptides have been
found in a wide array of animal species ranging from insects to lower
vertebrates and mammals (8). These peptides contribute to
innate host defense against a number of bacterial and fungal pathogens.
Mammalian defensins are small antimicrobial peptides (3.5 to 4.5 kDa)
that are characterized by the presence of six cysteines which form
three disulfide bonds, whose ordered array defines the classification
as
- or
-defensin (12, 13).
-defensins have been
described in leukocytes of cattle and fowl, as well as at mucosal
surfaces of different organ systems (17). Human
-defensins 1 and 2 (hBD-1 and hBD-2) are expressed in surface
organs, such as epithelia of the urinary, intestinal, and respiratory
tracts (3, 7, 14, 23). The cathelicidins are a distinct
family of antimicrobial peptides and are characterized by a highly
conserved signal sequence and proregion (called "cathelin") but
show substantial heterogeneity in their C-terminal domain that encodes
the mature peptide (24). The only human cathelicidin,
LL-37/hCAP-18, was isolated from human bone marrow. LL-37/hCAP-18 is
expressed in myeloid cells and is also found on body surfaces such as
skin and respiratory epithelia, where it is secreted into the airway
surface fluid (1, 4, 9).
Defects of the function of antimicrobial peptides have been implicated
in the development of human diseases such as cystic fibrosis (6,
20). However, lacking appropriate animal models, no final
conclusions can be drawn with respect to the role of these molecules in
the pathogenesis of human disease. Mice express several antimicrobial
peptides homologous to the human molecules, such as mouse
-defensins
1 to 4 or cathelin-related antimicrobial murine peptide (2, 5,
11, 16, 18, 19). For several reasons, murine models seem
inappropriate to study human disease. Mice do not express defensins in
neutrophils (10), whereas in humans these cells contain
large amounts of antimicrobial peptides of the defensin and
cathelicidin class. This may indicate that the murine and human innate
immune systems differ significantly. Furthermore, murine models often
do not reveal the characteristic pathology of human disease.
In the present study we describe the cloning of rhesus monkey
(Macaca mulatta) antimicrobial peptides of the
-defensin
and cathelicidin families. The newly identified molecules reveal a high
degree of homology to the human antimicrobial peptides and are
expressed in the same organs and cell types. Nonhuman primates may
represent valid animal models to study innate immune functions.
 |
MATERIALS AND METHODS |
Cloning of rhBD-1, rhBD-2, and rhLL-37 cDNA.
The cDNA
sequences of hBD-1 (GenBank accession number NM_005218), hBD-2 (GenBank
accession number NM_004942), and LL-37 (GenBank accession number
Z38026) were used to generate primers spanning the entire molecule.
Reverse-transcriptase PCR was used to clone the full-length cDNA
sequences of rhesus monkey peptides. Total RNA was isolated from lung
or bone marrow of a 3-year-old male rhesus monkey (Buckshire Farms,
Perkasie, Pa.) by using Trizol (Gibco BRL) and further purified to
poly(A)+ RNA using oligo(dT) columns (Qiagen).
Poly(A)+ RNA (approximately 100 ng) was reverse transcribed
using NotI-(dT)18 as primer (First-Strand cDNA
Synthesis kit; Pharmacia Biotech) and 10% of the reaction mixture was
used for a PCR. Specific primers to the molecules are listed in Table
1. PCR was carried out using a Hybaid
thermocycler. The PCR products were analyzed on a 1.5% agarose gel,
and bands of the calculated length were cut out and cloned into pGEM T
(Promega). Animal experiments were approved by the Institutional Animal
Care and Use Committees of the University of Pennsylvania or the
Primatenzentrum Göttingen, Göttingen, Germany.
Expression analysis.
All tissue samples were obtained from
the Primatenzentrum Göttingen and were formalin fixed and
paraffin embedded using routine methodology. Immunohistochemical
methods applying antibodies raised against the human homologous
peptides were used to analyze the tissue distribution of the
antimicrobial peptides. The antibodies were generated by performing a
standard immunization protocol in rabbits using peptides purified from
urine (hBD-1), isolated from a recombinant baculovirus system (hBD-2),
or synthesized chemically (LL-37) as described previously (3,
4). The antibodies were tested to be specific for the
corresponding antimicrobial peptide and showed no cross-reactivity with
the other antimicrobial peptides or other cationic substances such as
mucins, lactoferrin, or lysozyme. Comparisons of the immune and
preimmune sera in blotting experiments showed the specific reactivity
of the polyclonal antibodies (data not shown). Based on the high degree
of structural similarity between human and rhesus monkey antimicrobial
peptides, a cross-reactivity of the antibodies was predicted to be
likely. We used a two-step indirect immunohistochemical method.
Sections were deparaffinized in xylol (20 min), hydrated in serial
dilutions of ethanol, and brought into Tris-buffered saline (TBS, pH
7.4) for 5 min. To eliminate the endogenous peroxidase, the sections
were treated with 3% H2O2 for 5 min. After
washes in TBS three times, the sections were incubated with a 1:5
dilution of goat serum in TBS for 20 min to reduce unspecific
background staining. Sections were incubated with different dilutions
of the primary antibody in TBS (1:50 and 1:500) for 18 h at 4°C.
After three washes in TBS, the sections were incubated with the
biotinylated secondary goat anti-rabbit antibody (1:1000 in TBS) for 30 min. Then the sections were washed in TBS and incubated with
peroxidase-conjugated streptavidin lasting 20 min in a 1:150 dilution
with TBS. After washes, 6 mg of 3,3-diaminobenzidine-tetrahydrochloride (DAB) in 10 ml of distilled water with 2 drops of 3%
H2O2 were applied as chromogen. Alternatively,
the detection of the bound primary antibodies was carried out by using
the Histostain Plus staining kit (Zymed Laboratories Inc.) using
3-amino-9-ethylcarbazole (AEC) as chromogen according to the
manufacturer's instructions. The sections were dehydrated in serial
dilutions of ethanol, treated with xylol, and mounted. Negative
controls lacked the primary antibody or used preimmune serum instead.
Some sections were counterstained using acidic hematoxylin or the
periodic acid-schiff reaction using standard methods.
For lectin histochemistry, dehydrated sections were incubated for
1 h with a dilution of the biotinylated lectin peanut agglutinin (5 µg/ml in phosphate-buffered saline). After washes in
phosphate-buffered saline the same detection procedure was used, as
described above.
The staining intensity of cell types was evaluated using a
semiquantitative scoring system, as follows: no staining (0), low staining (1), intermediate staining (2), strong staining (3), and very
strong staining (4). The results were evaluated by three independent
investigators and averaged. For each organ or tissue, material from
three to four animals was used. Negative controls did not show any
signal above background.
Nucleotide sequence accession numbers.
The nucleotide
sequences of the identified antimicrobial peptides have been submitted
to GenBank and assigned the following accession numbers: rhBD-1,
AF288285; rhBD-2, AF288286; and rhLL-37/rhCAP-18, AF288284.
 |
RESULTS |
Structure of rhesus monkey antimicrobial peptides.
The cDNAs
of rhesus monkey antimicrobial peptides were cloned by using a reverse
transcriptase PCR methodology based on homology to the human molecules.
The degree of similarity on the nucleic level between human and rhesus
monkey BD-1 and BD-2 is 93.2 and 99.5%, respectively. Rhesus monkey
LL-37 (rhLL-37) revealed 99.6% sequence similarity to human LL-37. The
predicted amino acid sequences of rhesus monkey and human peptides are
shown in Fig. 1. Like the human
molecules, the monkey
-defensin molecules reveal the structural
hallmarks of this peptide family. The amino terminal prepro-portions of
the peptides contain several hydrophobic residues, which are
characteristic for
-defensins and are found in other
-defensin
family members expressed on mucosal surfaces. The putative mature
peptide contains six cysteine residues spaced in a typical array.
Several characteristic charged residues are present in the putative
mature peptide. Like its human homologue, rhLL-37 revealed a highly
conserved proregion of the molecule, called cathelin (Fig. 1). The
cloning procedures were repeated several times with identical results.

View larger version (37K):
[in this window]
[in a new window]
|
FIG. 1.
Comparison of the amino acid sequences of rhBD-1,
rhBD-2, and rhLL37/rhCAP-18 with their human homologues. Rhesus monkey
-defensins reveal a high degree of similarity to the human
molecules, and rhLL-37 is identical to LL-37, including the
cathelin-like proregion (amino acids 31 to 131 of the LL-37 sequence).
Conserved cysteines of the defensins are labeled by boxes.
|
|
Expression of rhesus monkey antimicrobial peptides.
The tissue
distribution of rhesus monkey antimicrobial peptides was analyzed at
the tissue level by using immunohistochemistry with three antibodies
raised against the homologous human substances. Peptides were detected
in epithelial and other cell types identical to the location of the
corresponding human antimicrobial molecules and showed an equivalent
expression pattern for most organs. Control experiments omitting the
primary antibody or using preimmune serum did not reveal a specific
signal (Fig. 2L and
3B).

View larger version (125K):
[in this window]
[in a new window]
|
FIG. 2.
Immunohistochemical detection of rhesus monkey
antimicrobial peptides in organs of the respiratory and
gastrointestinal tract. In large airways (A, rhBD-1; B, rhBD-2; C,
rhLL-37), all peptides were detected in ciliated epithelial cells. In
distal lung (D, rhBD-1; E, rhBD-2; F, rhLL-37), type II pneumocytes
revealed a positive signal for rhBD-2 (arrows), and alveolar
macrophages were stained with antibodies to all three antimicrobial
peptides. In the stomach, chief cells of the mucosa stained positive
for all three peptides (G, rhBD-1; H, rhBD-2; I, rhLL-37); however, the
staining pattern is specific for the peptides. Enterocytes of the small
(J, rhBD-1) and large bowel (K, rhBD-1) were stained diffusely positive
for the presence of the peptides. In the duodenum, cells located at the
basal portion of crypts were intensely stained for rhBD-1 (J, arrow).
In the subepithelial space of the intestinal mucosa, lymphocytes were
stained intensely with the hBD-1 antibodies (K, arrow). A preimmune
control section of colon showed no specific signal (L, rhBD-1
preimmune). The bar indicates 30 µm in panels A to F, 15 µm in
panel G, and 60 µm in panels H to L. As chromogens, we used DAB
(panels A to G, K, and L) or AEC (panels H, I, and J) (see Materials
and Methods).
|
|

View larger version (111K):
[in this window]
[in a new window]
|
FIG. 3.
Immunohistochemical detection of rhesus monkey
antimicrobial peptides in kidney (A, rhBD-1; B, rhBD-1 preimmune; C,
rhLL-37) and conjunctival tissue of the eye (D, rhBD-1; E, rhBD-2; F,
rhLL-37). The bar indicates 120 µm in panels A to C and 30 µm in
panels D to F. As chromogens, we used DAB (panels A, B, D, and F) or
AEC to (panels C and E).
|
|
In the respiratory tract (Table 2; Fig.
2), antimicrobial peptides are expressed predominantly in the large
airways, revealing a proximal-distal gradient. Defensins and the
cathelicidin are localized in ciliated cell types of the surface
epithelium as well as serous gland cells. A weak or no significant
signal was detectable in distal airway epithelia. Pneumocytes revealed
a positive signal for rhBD-2. Alveolar macrophages were stained with
the antibodies to the defensins and the cathelicidin (Fig. 2).
In the gastrointestinal tract, we analyzed the esophagus, stomach, and
small and large bowel, as well as the parotid gland and pancreas (Table
2; Fig. 2). In the gastric mucosa, the three antibodies stained chief
cells in the basal parts of the gastric mucosa. In the small and large
bowel, columnar absorptive cells of the surface epithelium stained
diffusely positive for the defensins and the cathelicidin. Pancreatic
secretory acini were diffusely stained for all three peptides.
Interlobular ducts of the parotid gland showed sparse positive cells
with the antibody to rhLL-37, whereas acinar secretory cells were
weakly positive for the defensins. In the kidney (Table 2; Fig. 3),
antibodies to all antimicrobial peptides stained distal tubules and
collecting ducts, as indicated by the staining of sections with peanut
agglutinin, which selectively labels these structures. In the male
reproductive system, cells in the seminiferous tubules, representing
most likely Sertoli cells, stained positively for the defensins. In the
female reproductive system, epithelia of nonlactating mammae stained
positive for all peptides. Glands of the uterus were labeled for rhBD-2
and rhLL-37. In other organs, goblet-like cells of the conjunctiva of
the eye were positive for rhBD-1 and rhBD-2 (Fig. 3). Endothelial cells
at several locations were positive when probed with antibody to
rhLL-37. Lymphocytes in a subepithelial location of the small and large
intestine that were identified by positive staining with antibody to
CD74 revealed a positive signal for the defensins.
 |
DISCUSSION |
In the present study, we described the isolation of cDNA sequences
from the rhesus monkey with high homology to the human antimicrobial
peptides hBD-1, hBD-2, and LL-37. We have named these antimicrobial
peptides rhBD-1, rhBD-2, and rhLL-37.
Analysis of the cloned sequences revealed a high degree of similarity
to the human molecules on the nucleic and amino acid level. Based on
the structural similarity, we used antibodies against the human
molecules for an expression analysis. Our data indicate that rhesus
monkey antimicrobial peptides are expressed in a similar pattern as
their human homologues (3, 7, 15). Immunohistochemical
analysis of human material revealed an identical tissue distribution of
-defensins (unpublished data). The most abundant peptide levels are
found in organs lining outer or inner body surfaces, such as organs of
the respiratory or gastrointestinal tract. Peptides are expressed in
secretory cells, indicating that their secreted forms contribute to the
host defense on body surfaces. The immunohistochemical analysis
revealed new insight into the biology of antimicrobial peptides,
expanding expression studies of human molecules on the transcript
level. In contrast to RNA studies, antimicrobial peptides were also
found in phagocytes (i.e., alveolar macrophages) and lymphocytes. Also,
goblet cells of the conjunctiva of the eye showed expression of
defensin molecules. These results highlight the functions of
antimicrobial peptides as direct endogenous antibiotics as well as
mediator substances in innate and adaptive immunity. The peptides
described in this study revealed a high degree of homology to human
molecules. The sequences of rhesus macaque
-defensins are also
closely related to the human molecules (21). Another class
of defensins, the so called
-defensins, has been described in
monkeys but has not yet been identified in humans (22).
The results presented in this study indicate that rhesus monkey mucosal
antimicrobial peptides resemble those of humans. Therefore, rhesus
monkeys may allow the development of valid animal models to study the
function of the innate immune system in health and disease, overcoming
limitations that are part of many murine model systems used to study
human disease.
 |
ACKNOWLEDGMENTS |
We thank F. J. Kaup, E. Fuchs, and K. Mätz-Rensing,
Deutsches Primatenzentrum, Göttingen, Germany, for supplying
formalin-fixed rhesus monkey tissue samples. The expert
immunohistochemical contribution of K. Verch from the Institute of
Anatomy of the University of Munich was greatly appreciated.
This study was supported by grants of the Cystic Fibrosis Foundation,
NIDDK, and NHLBI of the NIH, as well as Genovo, Inc., a biotechnology
company that J. Wilson founded and holds equity in. Robert Bals was
supported by the Deutsche Forschungsgemeinschaft (Ba 1641/1, Ba
1641/3-1).
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Medizinische
Klinik und Poliklinik I, Hospital of the University of Munich, Campus Großhadern, Schwerpunkt Pneumologie, Marchioninistr. 15, 81377 München, Germany. Phone: 49 (0)89 7095 3071. Fax: 49 (0)89 7095 8877. E-mail: rbals{at}med1.med.uni-muenchen.de.
 |
REFERENCES |
| 1.
|
Agerberth, B.,
H. Gunne,
J. Odeberg,
P. Kogner,
H. G. Boman, and G. H. Gudmundsson.
1995.
FALL-39, a putative human peptide antibiotic, is cysteine-free and expressed in bone marrow and testis.
Proc. Natl. Acad. Sci. USA
92:195-199[Abstract/Free Full Text].
|
| 2.
|
Bals, R.,
M. J. Goldman, and J. M. Wilson.
1998.
Mouse -defensin 1 is a salt-sensitive antimicrobial peptide present in epithelia of the lung and urogenital tract.
Infect. Immun.
66:1225-1232[Abstract/Free Full Text].
|
| 3.
|
Bals, R.,
X. Wang,
Z. Wu,
T. Freeman,
V. Banfa,
M. Zasloff, and J. Wilson.
1998.
Human beta-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung.
J. Clin. Investig.
102:874-880[Medline].
|
| 4.
|
Bals, R.,
X. Wang,
M. Zasloff, and J. M. Wilson.
1998.
The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface.
Proc. Natl. Acad. Sci. USA
95:9541-9546[Abstract/Free Full Text].
|
| 5.
|
Bals, R.,
S. Wattler,
M. Nehls,
R. Meegalla, and J. Wilson.
1999.
Mouse -defensin 3 is an inducible antimicrobial peptide expressed in the epithelia of multiple organs.
Infect. Immun.
67:3542-3547[Abstract/Free Full Text].
|
| 6.
|
Bals, R.,
D. Weiner, and J. Wilson.
1999.
The innate immune system in cystic fibrosis lung disease.
J. Clin. Investig.
103:303-307[Medline].
|
| 7.
|
Bensch, K.,
M. Raida,
H.-J. Magert,
P. Schulz-Knappe, and W.-G. Forssmann.
1995.
hBD-1: a novel -defensin from human plasma.
FEBS Lett.
368:331-335[CrossRef][Medline].
|
| 8.
|
Boman, H.
1991.
Antibacterial peptides: key components needed in immunity.
Cell
65:205-207[CrossRef][Medline].
|
| 9.
|
Cowland, J.,
A. Johnsen, and N. Borregaard.
1995.
hCAP-18, a cathelin/pro-bactenecin-like protein of human neutrophil specific granules.
FEBS Lett.
368:173-176[CrossRef][Medline].
|
| 10.
|
Eisenhauer, P. B., and R. I. Lehrer.
1992.
Mouse neutrophils lack defensins.
Infect. Immun.
60:3446-3447[Abstract/Free Full Text].
|
| 11.
|
Gallo, R.,
K. Kim,
M. Bernfield,
C. Kozak,
M. Zanetti,
L. Merluzzi, and R. Gennaro.
1997.
Identification of CRAMP, a cathelin-related antimicrobial peptide expressed in the embryonic and adult mouse.
J. Biol. Chem.
272:13088-13093[Abstract/Free Full Text].
|
| 12.
|
Ganz, T., and R. I. Lehrer.
1995.
Defensins.
Pharmacol. Ther.
66:191-205[CrossRef][Medline].
|
| 13.
|
Ganz, T., and J. Weiss.
1997.
Antimicrobial peptides of phagocytes and epithelia.
Semin. Hematol.
34:343-354[Medline].
|
| 14.
|
Harder, J.,
J. Bartels,
E. Christophers, and J.-M. Schroeder.
1997.
A peptide antibiotic from human skin.
Nature
387:861[CrossRef][Medline].
|
| 15.
|
Harder, J.,
R. Siebert,
Y. Zhang,
P. Matthiesen,
E. Christophers,
B. Schlegelberger, and J. M. Schroder.
1997.
Mapping of the gene encoding human beta-defensin-2 (DEFB2) to chromosome region 8p22-p23.1.
Genomics
46:472-475[CrossRef][Medline].
|
| 16.
|
Huttner, K. M.,
C. A. Kozak, and C. L. Bevins.
1997.
The mouse genome encodes a single homolog of the antimicrobial peptide human beta-defensin 1.
FEBS Lett.
413:45-49[CrossRef][Medline].
|
| 17.
|
Lehrer, R., and T. Ganz.
1999.
Antimicrobial peptides in mammalian and insect host defense.
Curr. Opin. Immunol.
11:23-27[CrossRef][Medline].
|
| 18.
|
Morrison, G.,
D. Davidson, and J. Dorin.
1999.
A novel mouse beta defensin, Defb2, which is upregulated in the airways by lipopolysaccharide.
FEBS Lett.
442:112-116[CrossRef][Medline].
|
| 19.
|
Morrison, G. M.,
D. J. Davidson,
F. M. Kilanowski,
D. W. Borthwick,
K. Crook,
A. I. Maxwell,
J. R. Govan, and J. R. Dorin.
1998.
Mouse beta defensin-1 is a functional homolog of human beta defensin-1.
Mamm. Genome
9:453-457[CrossRef][Medline].
|
| 20.
|
Smith, J.,
S. Travis,
E. Greenberg, and M. Welsh.
1996.
Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid.
Cell
85:229-236[CrossRef][Medline].
|
| 21.
|
Tang, Y. Q.,
J. Yuan,
C. J. Miller, and M. E. Selsted.
1999.
Isolation, characterization, cDNA cloning, and antimicrobial properties of two distinct subfamilies of alpha-defensins from rhesus macaque leukocytes.
Infect. Immun.
67:6139-6144[Abstract/Free Full Text].
|
| 22.
|
Tang, Y.-Q.,
J. Yaun,
G. Osapay,
C. Osapay,
D. Tran,
C. Miller,
A. Quellette, and M. Selsted.
1999.
A cyclic antimicrobial peptide produced in primate leukocytes by the ligation of two truncated alpha-defensins.
Science
286:498-502[Abstract/Free Full Text].
|
| 23.
|
Valore, E. V.,
C. H. Park,
A. J. Quayle,
K. R. Wiles,
P. B. McCray, Jr., and T. Ganz.
1998.
Human beta-defensin-1: an antimicrobial peptide of urogenital tissues.
J. Clin. Investig.
101:1633-1642[Medline].
|
| 24.
|
Zanetti, M.,
R. Gennaro, and D. Romeo.
1995.
Cathelicidins: a novel protein family with a common proregion and a variable C-terminal antimicrobial domain.
FEBS Lett.
374:1-5[CrossRef][Medline].
|
Clinical and Diagnostic Laboratory Immunology, March 2001, p. 370-375, Vol. 8, No. 2
1071-412X/01/$04.00+0 DOI: 10.1128/CDLI.8.2.370-375.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.